基于“肺与大肠相表里”理论探讨肠道菌群对肺癌影响
Exploring the influence of intestinal flora on lung cancer based on the theory of "the interior-exterior relationship between the lung and large intestine"
- 现代中医临床 2023年30卷第1期 页码：90-93
- 作者机构：
上海中医药大学附属市中医医院 上海 200071
- 作者简介：
张国磊，男，在读硕士生
#方志红，女，博士，主任医师，硕士生导师，E-mail：ffwf2001@126.com
- 基金信息：上海市科学技术委员会科研计划项目(22Y11921300;19ZR1452200);全国中医药创新骨干人才培训项目;上海医学创新发展基金“未来计划”中医药传承类项目(WLJH2021ZY-MZY040)
DOI：10.3969/j.issn.2095-6606.2023.01.022
中图分类号： R259纸质出版日期：2023-01-30，
收稿日期：2022-03-22，
- 稿件说明：
移动端阅览
张国磊, 王宇立, 诸君, 等. 基于“肺与大肠相表里”理论探讨肠道菌群对肺癌影响[J]. 现代中医临床, 2023,30(1):90-93.
ZHANG Guolei, WANG Yuli, ZHU Jun, et al. Exploring the influence of intestinal flora on lung cancer based on the theory of "the interior-exterior relationship between the lung and large intestine"[J]. Modern Chinese Clinical Medicine, 2023,30(1):90-93.
张国磊, 王宇立, 诸君, 等. 基于“肺与大肠相表里”理论探讨肠道菌群对肺癌影响[J]. 现代中医临床, 2023,30(1):90-93. DOI： 10.3969/j.issn.2095-6606.2023.01.022.
ZHANG Guolei, WANG Yuli, ZHU Jun, et al. Exploring the influence of intestinal flora on lung cancer based on the theory of "the interior-exterior relationship between the lung and large intestine"[J]. Modern Chinese Clinical Medicine, 2023,30(1):90-93. DOI： 10.3969/j.issn.2095-6606.2023.01.022.
摘要
肺癌是当前世界性的重大疾病之一，肠道菌群是当前研究的热点，肠道菌群失调与肺癌之间存在相关性，但具体机制尚不明确。基于“肺与大肠相表里”理论，分别从“肺与大肠相表里”的理论渊源、生理基础、病理传变及治法方药等方面进行梳理，并从西医学角度阐述肠道菌群可通过炎症、免疫等途径影响肺癌的发生发展，同时影响肺癌化疗、免疫治疗等治疗效果。基于“肺与大肠相表里”经典理论探讨肠道菌群对肺癌的影响，可为肺癌的治疗提供新思路。
Abstract
Lung cancer is one of the major diseases in the world
and intestinal flora is currently a hot topic of research. There is a correlation between intestinal flora dysbiosis and lung cancer
but the underlying mechanism is still unclear. Based on the theory of "the interior-exterior relationship between the lung and large intestine"
this study explores the theoretical foundation
physiological basis
pathological transmission and treatment prescriptions of lung cancer. From the perspective of modern medicine
it is further proposed that intestinal flora can influence the development of lung cancer through inflammation and immunity
and affect the therapeutic effects of chemotherapy and immunotherapy for lung cancer
with the aim to provide new ideas for the treatment of lung cancer.
关键词
肺大肠相表里肺癌肠道菌群
Keywords
lunglarge intestinethe interior-exterior relationshiplung cancerintestinal flora.
references
BRAY F，FERLAY J，SOERJOMATARAM I，et al.Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin，2018，68(6): 394-424.
ZHENG R S，ZHANG S W，ZENG H M，et al.Cancer incidence and mortality in China，2016[J].J Natl Cancer Cent，2022，2(1): 1-9.
ZENG H M,CHEN W Q,ZHENG R S,et al.Changing cancer survival in China during 2003-15:a pooled analysis of 17 population-based cancer registries[J/OL].Lancet Glob Health,2018,6(5):e555-e567[2021-11-17].https://www.ncbi.nlm.nih.gov/pmc/articles/PMID29653628/.
SENDER R，FUCHS S，MILO R.Are we really vastly outnumbered revisiting the ratio of bacterial to host cells in humans[J].Cell，2016，164(3): 337-340.
GOODRICH J K，WATERS J L，POOLE A C，et al.Human genetics shape the gut microbiome[J].Cell，2014，159(4): 789-799.
巢元方.诸病源候论[M].鲁兆麟，点校.沈阳：辽宁科学技术出版社，1997.
孙思邈.华佗神方[M].杨金生，赵美丽，段志贤，点校.北京：中国古籍出版社，1992: 38.
黄元御.素灵微蕴[M].杨枝青，校注.北京：中国古籍出版社，2015: 90.
唐容川.中西汇通医经精义[M].梁宝祥，于新力，于雪梅，等，校注.太原：山西科学技术出版社，2013: 29.
华佗.中藏经[M].农汉才，点校.北京：学苑出版社，2007: 39.
陈无择.三因极一病证方论[M].北京：中国中医药出版社，2007: 212.
王庆国.伤寒论选读[M].北京：中国中医药出版社，2016: 74.
范永升.金匮要略[M].北京：中国中医药出版社，2016: 142.
杨士瀛.仁斋直指[M].北京：中国古籍出版社，2016: 124.
吴瑭.温病条辨[M].北京：中国医药科技出版社，2013: 25-26.
张桥，乐世俊，陈艳琰，等.中药调节肠道菌群治疗慢性腹泻的研究进展[J].中草药，2022，53(8): 2539-2549.
NI Y，LOHINAI Z，HESHIKI Y，et al.Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients[J].ISME J，2021，15(11): 3207-3220.
KANG Y B，CAI Y，ZHANG H. Gut microbiota and allergy/asthma: from pathogenesis to new therapeutic strategies[J].Allergol Immunopathol (Madr)，2017，45(3): 305-309.
NAGASAKA M,SEXTON R,ALHASAN R,et al. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-a review[J/OL].Crit Rev Oncol Hematol,2019,145:102841[2021-11-17].https://www.ncbi.nlm.nih.gov/pmc/articles/PMID31884204/.
MAO Q,JIANG F,YIN R,et al.Interplay between the lung microbiome and lung cancer[J/OL].Cancer Lett,2018,415:40-48[2021-11-17].https://www.ncbi.nlm.nih.gov/pmc/articles/PMID29197615/.
BABIC A,SCHNURE N,NEUPANE N P,et al.Plasma inflammatory cytokines and survival of pancreatic cancer patients[J/OL].Clin Transl Gastroenterol,2018,9(4):145[2021-11-17].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915593/.
赵婷婷，张清媛.PD－1/PD-L1介导的肿瘤免疫逃逸在肿瘤微环境中的研究进展[J].现代肿瘤医学，2021，29(3): 520-523.
BIRAGYN A,FERRUCCI L.Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammaging[J/OL].Lancet Oncol,2018,19(6):e295-e304[2021-11-17].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047065/.
牛玉苗，严翔，齐宏妍，等.肿瘤微环境中主要炎症细胞因子对PD-L1表达调控的研究进展[J].中国病理生理杂志，2020，36(9): 1704-1708.
蒋海燕，张士强，杨蕴，等.基于“肺与大肠相表里”研究健脾固肠方通过调节肠道免疫平衡抑制肺癌小鼠肿瘤转移的机制[J].上海中医药杂志，2020，54(3): 91-96.
GUI Q F，LU H F，ZHANG C X，et al. Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model[J].Genet Mol Res，2015，14(2): 5642-5651.
GELLER L T,BARZILY-ROKNI M,DANINO T,et al.Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine[J/OL].Science,2017,357(6356):1156-1160[2021-11-17].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727343/.
KATAYAMA Y，YAMADA T，SHIMAMOTO T，et al.The role of the gut microbiome on the efficacy of immune checkpoint inhibitors in Japanese responder patients with advanced non-small cell lung cancer[J].Transl Lung Cancer Res，2019，8(6): 847-853.
周卉洁，锁娇娇，朱江.人体菌群与肺癌的治疗相关性[J].中国肺癌杂志，2019，22(7): 464-469.
SNYDER A，PAMER E，WOLCHOK J. Could microbial therapy boost cancer immunotherapy？[J].Science，2015，350(6264): 1031-1032.
孙小单，王天鸣，李慧，等.人参皂苷Rh_2抑制人非小细胞肺癌细胞增殖的机制研究[J].中草药，2022，53(2): 441-448.
HUANG J M,Liu D,Wang Y W,et al.Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio,potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy[J/OL].Gut,2022,71:734-745[2021-11-17].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921579/.
赵华，晋玮，吴昊，等.基于肺与大肠相表里理论的健脾固肠方对非小细胞肺癌患者肠道菌群及免疫功能的影响[J].实用药物与临床，2022，25(7): 592-595.
孔明，杨亚娟，王怡丹.化瘀抗癌汤灌肠联合耳穴贴压治疗肺癌患者的效果及对肠道菌群的影响[J].交通医学，2021，35(4): 365-367.
0
浏览量
179
下载量
0
CSCD
- 网络PDF下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies